Multiple Sclerosis Relapsing-remitting
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis Relapsing-remitting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Maximizing Outcome of Multiple Sclerosis Transplantation [Phase 3]
Phase 3 trial update for a transplantation strategy in relapsing-remitting multiple sclerosis; trial terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS [Phase 2]
Phase 2 clinical trial assessing the HERV-W Env antagonist GNbAC1 for efficacy in relapsing-remitting multiple sclerosis has completed.
-
EMA withdrawal · 2020-06-17EMA Application withdrawn: Fingolimod Mylan (fingolimod hydrochloride) — Mylan Ireland Limited
The EMA withdrew the application for Fingolimod Mylan (fingolimod hydrochloride) from consideration for relapsing-remitting multiple scleros…
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) [Phase 3]
Phase 3 trial updating ocrelizumab in relapsing-remitting MS patients with suboptimal response to prior DMT has completed and results posted…
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Light Therapy as Treatment for Fatigue in Multiple Sclerosis [NA]
A completed clinical trial investigating light therapy as a treatment for fatigue in relapsing-remitting multiple sclerosis with results pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS) [Phase 2]
A Phase 2 pilot trial in relapsing-remitting multiple sclerosis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 2]
A Phase 2 pilot trial evaluating domperidone in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: ACTH for Fatigue in Multiple Sclerosis Patients [Phase 3]
Phase 3 clinical trial evaluating ACTH for fatigue in patients with Relapsing-Remitting Multiple Sclerosis has completed with results posted…
-
CLINICAL_TRIALS research · 2019-08-12Clinical Trial Update: Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis [NA]
A completed clinical trial evaluating a modified Paleolithic dietary intervention for relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial assessing the impact of vitamin D supplementation in patients with relapsing-remitting multiple sclerosis and vitam…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate [Phase 4]
Phase 4 clinical trial update monitoring patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis [Phase 4]
Phase 4 trial investigating the effect of dimethyl fumarate on T cells in patients with relapsing-remitting multiple sclerosis has completed…
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis [Phase 4]
Phase 4 trial update for Rebif in relapsing multiple sclerosis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Healthy Volunteer Study Using 3 Different Formulations of Firategrast [Phase 1]
Phase 1 healthy volunteer study evaluating three formulations of Firategrast; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant [NA]
The completed clinical trial focuses on cognitive disability and quality of life in relapsing-remitting multiple sclerosis patients treated …
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)
An observational study evaluating Rebismart 2.0 plus MSdialog in relapsing-remitting multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study
This completed clinical trial update reports on a study assessing lesion activity in relapsing-remitting multiple sclerosis patients treated…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health [NA]
Clinical trial update reporting pharmacokinetics of vitamin D in multiple sclerosis and healthy individuals; study completed with posted res…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One [Phase 3]
Phase 3 head-to-head trial comparing alemtuzumab with Rebif in relapsing-remitting multiple sclerosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness [Phase 4]
Phase 4 trial assessing natalizumab’s effects on sleep parameters in relapsing-remitting multiple sclerosis patients experiencing fatigue or…
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects [Phase 3]
Phase 3 trial evaluating the tolerability of Rebif injections in relapsing-remitting multiple sclerosis with and without the Rebiject Mini a…
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS) [Phase 3]
A Phase 3 study comparing Rebif and Avonex for relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) Relapses [Phase 3]
Phase 3 clinical trial evaluating oral methylprednisolone versus intravenous methylprednisolone for treatment of relapses in relapsing-remit…
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS
A Biogen-sponsored trial evaluating compliance with Avonex PS in patients with relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2011-10-18Clinical Trial Update: The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis [EARLY_Phase 1]
This clinical trial update describes a Phase 1 study examining whether aerobics training improves balance in relapsing-remitting multiple sc…